128 related articles for article (PubMed ID: 27540529)
21. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
22. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
Carroll VA; Ashcroft M
Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
[TBL] [Abstract][Full Text] [Related]
23. Phenethyl isothiocyanate, by virtue of its antioxidant activity, inhibits invasiveness and metastatic potential of breast cancer cells: HIF-1α as a putative target.
Sarkar R; Mukherjee S; Biswas J; Roy M
Free Radic Res; 2016; 50(1):84-100. PubMed ID: 26480821
[TBL] [Abstract][Full Text] [Related]
24. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia-inducible transcription factor-1alpha promotes hypoxia-induced A549 apoptosis via a mechanism that involves the glycolysis pathway.
Luo F; Liu X; Yan N; Li S; Cao G; Cheng Q; Xia Q; Wang H
BMC Cancer; 2006 Jan; 6():26. PubMed ID: 16438736
[TBL] [Abstract][Full Text] [Related]
26. FBP1 modulates cell metabolism of breast cancer cells by inhibiting the expression of HIF-1α.
Shi L; He C; Li Z; Wang Z; Zhang Q
Neoplasma; 2017; 64(4):535-542. PubMed ID: 28485159
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of hypoxia-inducible factor-1 suppresses malignant biological behavior of triple-negative breast cancer cells.
Wang F; Chang M; Shi Y; Jiang L; Zhao J; Hai L; Sharen G; Du H
Int J Clin Exp Med; 2014; 7(11):3933-40. PubMed ID: 25550901
[TBL] [Abstract][Full Text] [Related]
28. M410, a combretastatin A4 analogue, disrupts microtubules and inhibits HIF-1α in human breast cancer cells.
Yang H; Xia Q; Zou Y; Wang K; Jiang W; Cai Y
Oncol Rep; 2015 Jul; 34(1):334-40. PubMed ID: 25976207
[TBL] [Abstract][Full Text] [Related]
29. The Effect of Lactobacillus crispatus and Lactobacillus rhamnosusCulture Supernatants on Expression of Autophagy Genes and HPV E6 and E7 Oncogenes in The HeLa Cell Line.
Motevaseli E; Azam R; Akrami SM; Mazlomy M; Saffari M; Modarressi MH; Daneshvar M; Ghafouri-Fard S
Cell J; 2016; 17(4):601-7. PubMed ID: 26862519
[TBL] [Abstract][Full Text] [Related]
30. Gli-1 is crucial for hypoxia-induced epithelial-mesenchymal transition and invasion of breast cancer.
Lei J; Fan L; Wei G; Chen X; Duan W; Xu Q; Sheng W; Wang K; Li X
Tumour Biol; 2015 Apr; 36(4):3119-26. PubMed ID: 25501705
[TBL] [Abstract][Full Text] [Related]
31. Anterior gradient 2 is a binding stabilizer of hypoxia inducible factor-1α that enhances CoCl2 -induced doxorubicin resistance in breast cancer cells.
Li Z; Zhu Q; Hu L; Chen H; Wu Z; Li D
Cancer Sci; 2015 Aug; 106(8):1041-9. PubMed ID: 26079208
[TBL] [Abstract][Full Text] [Related]
32. Roles of MALAT1 in development and migration of triple negative and Her-2 positive breast cancer.
Xiping Z; Bo C; Shifeng Y; Feijiang Y; Hongjian Y; Qihui C; Binbin T
Oncotarget; 2018 Jan; 9(2):2255-2267. PubMed ID: 29416769
[TBL] [Abstract][Full Text] [Related]
33. hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer.
Camps C; Buffa FM; Colella S; Moore J; Sotiriou C; Sheldon H; Harris AL; Gleadle JM; Ragoussis J
Clin Cancer Res; 2008 Mar; 14(5):1340-8. PubMed ID: 18316553
[TBL] [Abstract][Full Text] [Related]
34. [Regulation of hypoxia inducible factor-1α on permeability of vascular endothelial cells and the mechanism].
Hu DL; Yu YX; Liang R; Zhou SY; Duan SL; Jiang ZY; Meng CY; Jiang W; Wang H; Sun YX; Fang LS
Zhonghua Shao Shang Za Zhi; 2019 Mar; 35(3):209-217. PubMed ID: 30897868
[No Abstract] [Full Text] [Related]
35. Fucoidan inhibits epithelial-to-mesenchymal transition via regulation of the HIF-1α pathway in mammary cancer cells under hypoxia.
Li W; Xue D; Xue M; Zhao J; Liang H; Liu Y; Sun T
Oncol Lett; 2019 Jul; 18(1):330-338. PubMed ID: 31289504
[TBL] [Abstract][Full Text] [Related]
36. Chlorogenic acid inhibits hypoxia-induced angiogenesis via down-regulation of the HIF-1α/AKT pathway.
Park JJ; Hwang SJ; Park JH; Lee HJ
Cell Oncol (Dordr); 2015 Apr; 38(2):111-8. PubMed ID: 25561311
[TBL] [Abstract][Full Text] [Related]
37. HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model.
Kim DH; Sung B; Kim JA; Kang YJ; Hwang SY; Hwang NL; Suh H; Choi YH; Im E; Chung HY; Kim ND
Int J Oncol; 2017 Aug; 51(2):715-723. PubMed ID: 28656256
[TBL] [Abstract][Full Text] [Related]
38. Bisphenol A induces proliferative effects on both breast cancer cells and vascular endothelial cells through a shared GPER-dependent pathway in hypoxia.
Xu F; Wang X; Wu N; He S; Yi W; Xiang S; Zhang P; Xie X; Ying C
Environ Pollut; 2017 Dec; 231(Pt 2):1609-1620. PubMed ID: 28964603
[TBL] [Abstract][Full Text] [Related]
39. Expression of hypoxia-inducible factor-1alpha and cell cycle proteins in invasive breast cancer are estrogen receptor related.
Bos R; van Diest PJ; van der Groep P; Shvarts A; Greijer AE; van der Wall E
Breast Cancer Res; 2004; 6(4):R450-9. PubMed ID: 15217513
[TBL] [Abstract][Full Text] [Related]
40. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
Lim CS; Kiriakidis S; Paleolog EM; Davies AH
J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
